Login / Signup

PCSK9 is a promising prognostic marker in patients with advanced NSCLC.

Aldo BonaventuraFrancesco GrossiFabrizio Montecucco
Published in: Cancer immunology, immunotherapy : CII (2020)
Keyphrases
  • small cell lung cancer
  • advanced non small cell lung cancer
  • low density lipoprotein
  • brain metastases
  • epidermal growth factor receptor